Allelix Genotype Report

Source: demo_23andme.txt · Annotators: clinvar (GRCh37:2026-06-06; GRCh38:2026-06-06), pharmgkb (2026-06-09), gwas (2026-06-09), gnomad (4.1), alphamissense (2023.2), cadd (v1.7) · Generated 2026-06-12 09:11 UTC

Informational only. This report is informational research output. It surfaces classifications made by external databases (ClinVar, PharmGKB, …) for variants present in the input genotype file. It is not medical advice and not a diagnosis. Every classification is attributed to its source database; Allelix does not independently classify variants.
Reading This Report

Pseudogene cross-hybridization

Some genes have known pseudogenes with high sequence similarity (e.g., PKD1 has six pseudogenes sharing >97% identity). Array-based genotyping probes can cross-hybridize, producing false genotype calls. If a result seems inconsistent with your health history, confirmatory testing by a different method is recommended.

ClinVar aggregation

ClinVar aggregates submissions from multiple sources. Different submitters may classify the same variant differently, and significance labels may be paired with conditions from a different submitter’s entry. Single-submitter entries carry less weight than expert-panel-reviewed classifications.

Carrier vs. affected

A variant classified as pathogenic in a recessive condition requires two copies to cause disease. If you are heterozygous (one copy), you are a carrier. Carrier status does not typically cause symptoms but may be relevant for family planning.

Confirmatory testing

No genotyping platform is 100% accurate. Clinically significant findings should be confirmed with an independent method before making medical decisions.

Understanding Magnitude Scores

Each annotation source uses its own criteria to assign a magnitude score (0–10) that reflects clinical importance. Higher scores warrant more attention. The score shown in the table is the maximum across all source annotations for that variant.

ClinVar (clinical significance)

9Pathogenic
8Pathogenic (single submitter / no assertion criteria)
7Likely pathogenic
5Uncertain significance / conflicting
4Risk factor / drug response / association
3Likely benign
1Benign

PharmGKB (pharmacogenomic evidence)

9Level 1A — CPIC guideline or FDA label
8Level 1B — strong clinical evidence
6Level 2A — moderate evidence
5Level 2B — moderate (weaker replication)
4Level 3 — low evidence or annotation only

GWAS Catalog (trait associations)

6p < 5×10-8 (genome-wide)
4p < 5×10-6 (suggestive)
3p < 1×10-4 (nominal)

SNPedia (community-curated)

Magnitude is assigned directly by community editors (0–10 scale). Higher scores indicate greater clinical or personal relevance as judged by contributors. See SNPedia’s magnitude documentation for details.

CADD (variant deleteriousness)

CADD PHRED scores rank how deleterious a variant is relative to all possible human SNVs. Higher scores = more likely to be deleterious.

≥ 30Top 0.1% most deleterious
≥ 20Top 1% most deleterious
≥ 10Top 10% most deleterious
< 10Below top 10%

AlphaMissense (missense pathogenicity)

DeepMind’s protein-structure-based pathogenicity prediction for missense variants. Score 0–1; higher = more likely pathogenic.

≥ 0.564Likely pathogenic
0.340 – 0.564Ambiguous
< 0.340Likely benign
Sample
(unknown)
Format
23andMe
Build
GRCh37
Variants
306
Bad
32
Good
0
Total Annotations
358
Source-specific thresholds. The global minimum magnitude is 5.0, but lower thresholds apply to: SNPEDIA (mag ≥ 2.0). Some rows below the global threshold may appear from these sources.
Mag▼GeneGenotypeReputeSummary
9HTR4CTNeutral[GWAS Catalog] Chronic obstructive pulmonary disease liability (machine learning-based score)
9STAT4CTNeutral[GWAS Catalog] Systemic lupus erythematosus (MTAG)
9LPAAANeutral[GWAS Catalog +4] Aortic stenosis
9LINC02571 - HLA-BCTNeutral[GWAS Catalog] Cutaneous psoriasis
9HTRA1-AS1, ARMS2GTNeutral[GWAS Catalog +1] Age-related macular degeneration (choroidal neovascularisation)
9SLC2A9CTNeutral[GWAS Catalog] Gout and other crystal arthrop (PheCode 274)
9CDKN2B-AS1TTNeutral[GWAS Catalog] Type 2 diabetes (PheCode 250.2)
9MTNR1BCGNeutral[GWAS Catalog] Fasting glucose
9PTPN11AGNeutral[GWAS Catalog] Hypothyroidism
9HHEX - Y_RNACTNeutral[GWAS Catalog] Type 2 diabetes
9ESR2, SYNE2AANeutral[GWAS Catalog] Atrial fibrillation
9TPOCCNeutral[GWAS Catalog] Hypothyroidism (PheCode 244)
9LAMA2AANeutral[GWAS Catalog] Refractive error
9IRF4CTNeutral[GWAS Catalog +2] Neoplasm of uncertain behavior of skin (PheCode 173)
9INSRACNeutral[GWAS Catalog] Benign nodular goiter
9GCKRCTNeutral[GWAS Catalog] Gout (PheCode 274.1)
9CELSR2GTNeutral[GWAS Catalog +2] Familial combined hyperlipidemia defined by Consensus criteria
9CYP2R1GGNeutral[GWAS Catalog] Vitamin deficiency (PheCode 261)
9RN7SKP61 - MRPS17P3AANeutral[GWAS Catalog] Craniofacial microsomia
9CFHGTNeutral[GWAS Catalog] Degeneration of macula and posterior pole of retina (PheCode 362.2)
9CDKN2B-AS1AANeutral[GWAS Catalog +1] Coronary artery / coronary heart disease (including heart attack, angina)
9FTOTTNeutral[GWAS Catalog +1] Type 2 diabetes (PheCode 250.2)
9GDF5AGNeutral[GWAS Catalog] Physical function (baseline)
9FTOTTNeutral[GWAS Catalog] Morbid obesity (PheCode 278.11)
9TOMM40AGNeutral[GWAS Catalog +1] Alzheimer's disease or family history of Alzheimer's disease
9SHBGGGNeutral[GWAS Catalog] Hypogonadism
9MC1RCCNeutral[GWAS Catalog +1] Neoplasm of uncertain behavior of skin (PheCode 173)
9CYP4F2CTNeutral[PharmGKB +2] PharmGKB: warfarin — Patients with the rs2108622 CT genotype may have increased warfarin dosage requirements as compared to patients with the CC genotype. However, conflicting evidence has been reported. Other genetic and clinical factors may also affect warfarin dosage requirements.
9ACADLGTNeutral[GWAS Catalog] Urinary metabolite modules (eigenmetabolites) in chronic kidney disease
9F11, F11-AS1CCNeutral[GWAS Catalog] Other venous embolism and thrombosis (PheCode 452)
9TERTACNeutral[GWAS Catalog] Seborrheic keratosis (PheCode 702.2)
9ZBTB38ACNeutral[GWAS Catalog] Physical function (baseline)
9CTLA4 - ICOSGGNeutral[GWAS Catalog] Hypothyroidism NOS (PheCode 244.4)
9HLA-DQB1 - MTCO3P1ATNeutral[GWAS Catalog] Hypothyroidism NOS (PheCode 244.4)
9ATXN2, SH2B3CTNeutral[GWAS Catalog +1] Hypothyroidism
9SNCACTNeutral[GWAS Catalog] Parkinson's disease or first degree relation to individual with Parkinson's disease
9CYP2B6GTNeutral[PharmGKB +3] HIV infectious disease
9CAV1AANeutral[GWAS Catalog] Atrial fibrillation
9APOETTNeutral[GWAS Catalog +2] Alzheimer's disease
9GCGGNeutral[GWAS Catalog] Vitamin deficiency (PheCode 261)
9COMTAANeutral[GWAS Catalog +1] Plasma 2-O-methylascorbic acid levels in chronic kidney disease
9AHSG, HRG-AS1CTNeutral[GWAS Catalog] Serum calciprotein particle maturation time (T50)
9CDKN2B-AS1AANeutral[GWAS Catalog] Coronary artery disease
9SLC22A11 - SLC22A12TTNeutral[GWAS Catalog] Gout (PheCode 274.1)
9ABOTTNeutral[GWAS Catalog] Venous thromboembolism
9ADRA2AGGBad[ClinVar] Lipodystrophy, familial partial, type 8
9SPC25, G6PC2CTNeutral[GWAS Catalog] Glycated hemoglobin levels
9LDLRGGNeutral[GWAS Catalog] Familial combined hyperlipidemia defined by Consensus criteria
9APOA5AANeutral[GWAS Catalog] Metabolic syndrome
9PHTF1 - RSBN1CCNeutral[GWAS Catalog] Hypothyroidism (PheCode 244)
9LINC01438 - MIR297CTNeutral[GWAS Catalog] Atrial fibrillation (MTAG)
9PCAT1, CASC8, POU5F1B, CCAT2TTNeutral[GWAS Catalog] Colorectal cancer
9POU5F1B, PCAT1, CASC8CCNeutral[GWAS Catalog] Colorectal cancer
9SMIM38 - MYEOVAGNeutral[GWAS Catalog] Cancer of prostate (PheCode 185)
9TBX3-AS1 - UBA52P7TTNeutral[GWAS Catalog] Spatial QRS-T angle
9GCKAGNeutral[GWAS Catalog] Glycated hemoglobin levels
9CELSR2AGNeutral[GWAS Catalog] Hyperlipidemia (PheCode 272.1)
9ADGRG6GTNeutral[GWAS Catalog] Chronic obstructive pulmonary disease liability (machine learning-based score)
9CDKAL1AGNeutral[GWAS Catalog] Type 2 diabetes
9LIN28B-AS1CTNeutral[GWAS Catalog] Menarche (age at onset)
9PTCSC2AGNeutral[GWAS Catalog +1] Hypothyroidism
9TCF7L2CCNeutral[GWAS Catalog +2] Type 2 diabetes
9HMGA2 - MIR6074GTNeutral[GWAS Catalog] Physical function (baseline)
9VEGFA - LINC02537AANeutral[GWAS Catalog] Hypothyroidism
9PTCSC2CTNeutral[GWAS Catalog] Hypothyroidism
9FAM13BTTNeutral[GWAS Catalog] Atrial fibrillation
9CDKAL1ACNeutral[GWAS Catalog] Type 2 diabetes
9PTCSC2AGNeutral[GWAS Catalog +1] Thyroid problems
9VKORC1CTNeutral[PharmGKB +8] PharmGKB: warfarin — Patients with the rs9923231 CT genotype may require a decreased dose of warfarin as compared to patients with the CC genotype or an increased dose as compared to patients with the TT genotype. Other genetic and clinical factors may also influence warfarin dose requirement.
8CFHACNeutral[GWAS Catalog +1] Age-related macular degeneration
8IL23RGGNeutral[GWAS Catalog +3] Inflammatory bowel disease
8HLA-DRB1 - HLA-DQA1AGNeutral[GWAS Catalog +2] Multiple sclerosis
8VKORC1AGNeutral[PharmGKB +1] PharmGKB: warfarin — Patients with the rs2359612 AG genotype may require a decreased dose of warfarin as compared to patients with the GG genotype. Other genetic and clinical factors may also influence dose of warfarin.
8VKORC1CGNeutral[PharmGKB +1] PharmGKB: warfarin — Patients with the rs8050894 CG genotype may require a lower dose of warfarin as compared to patients with the CC genotype. Other genetic and clinical factors may also influence warfarin dosage requirements.
8VKORC1AGNeutral[PharmGKB +3] PharmGKB: warfarin — Patients with the rs9934438 AG genotype may require a lower dose of warfarin as compared to patients with the GG genotype, and a higher dose as compared to patients with the AA genotype. However, conflicting evidence has been reported. Other clinical and genetic factors may also influence warfarin dose requirements.
7ADRB2AGNeutral[PharmGKB +1] Asthma
7SLC19A1CTNeutral[PharmGKB +1] Rheumatoid arthritis
7CDKN2BAABad[ClinVar] Three Vessel Coronary Disease
7VKORC1ACNeutral[PharmGKB +1] PharmGKB: warfarin — Patients with the rs2884737 AC genotype may require higher dose of warfarin as compared to patients with the CC genotype. Other clinical and genetic factors may also influence warfarin dosage requirements.
7VHLGGBad[ClinVar] Von Hippel-Lindau syndrome
6ABCB1TTNeutral[ClinVar] Tramadol response
6CYP2D6CTNeutral[ClinVar] Tramadol response
6ABCB1CCNeutral[ClinVar] Tramadol response
6ABCB1CGNeutral[ClinVar] Tramadol response
6ARVCFAGNeutral[ClinVar] Tramadol response
6ARVCFTTNeutral[ClinVar] Tramadol response
6CHRNA5AGNeutral[ClinVar +1] Susceptibility to severe coronavirus disease (COVID-19) due to high levels of fibrinogen and C-reactive protein
6ABCB1CTNeutral[ClinVar] Tramadol response
6KIF6GGNeutral[ClinVar] pravastatin response - Efficacy
6ABCB1CTNeutral[ClinVar] Tramadol response
6ABCB1TTNeutral[ClinVar] Tramadol response
6ABCB1GGNeutral[ClinVar] Tramadol response
6ABCB1AGNeutral[ClinVar] Tramadol response
6ABCB1CCNeutral[ClinVar] Tramadol response
6DIO1AANeutral[ClinVar] Levothyroxine response
6XRCC1CCNeutral[ClinVar +1] Spinocerebellar ataxia, autosomal recessive 26
6CYP2D6GTNeutral[ClinVar] Tramadol response
6SCN1ATTNeutral[ClinVar +1] Early-infantile DEE
6APOEGTNeutral[ClinVar] Warfarin response
6APOECCNeutral[ClinVar] Warfarin response
6OPRM1GGNeutral[ClinVar] Tramadol response
6OPRM1AANeutral[ClinVar] Tramadol response
6ITPAACNeutral[ClinVar +1] Developmental and epileptic encephalopathy, 35
6CYP19A1AANeutral[ClinVar] Letrozole response
6APOEAGNeutral[ClinVar] Warfarin response
6OPRM1AGNeutral[ClinVar] Tramadol response
6ABCB1GGNeutral[ClinVar] Tramadol response
6IRF5AGBad[ClinVar] Systemic lupus erythematosus, susceptibility to, 10
6TCF7L2CGBad[ClinVar] Diabetes mellitus type 2, susceptibility to
6IL1BAGBad[ClinVar] Gastric cancer susceptibility after h. pylori infection
6SCGB3A2AGBad[ClinVar] Inherited susceptibility to asthma
6EPOACBad[ClinVar] Microvascular complications of diabetes, susceptibility to, 2
6USF1TTBad[ClinVar] Hyperlipidemia, familial combined, susceptibility to
6LOXL1CTBad[ClinVar] Exfoliation syndrome, susceptibility to
6ESR1CTBad[ClinVar] Myocardial infarction, susceptibility to
6XBP1CGBad[ClinVar] ClinVar classifies this allele as risk factor
6SLC11A1CTBad[ClinVar] Mycobacterium tuberculosis, susceptibility to infection by
6GABRA2ATBad[ClinVar] Alcoholism, susceptibility to
6GABRA2ATBad[ClinVar] Alcoholism, susceptibility to
6GABRA2CTBad[ClinVar] Alcoholism, susceptibility to
6KCNB2AABad[ClinVar] Colorectal cancer
6USF1AABad[ClinVar] Hyperlipidemia, familial combined, susceptibility to
6CD244CCBad[ClinVar] Rheumatoid arthritis
6GCLMAGBad[ClinVar] Myocardial infarction, susceptibility to
6IGF2BP2TTBad[ClinVar] Diabetes mellitus type 2, susceptibility to
6CHI3L1CCBad[ClinVar] Asthma-related traits, susceptibility to, 7
6CAPN10CTBad[ClinVar] Type 2 diabetes mellitus 1, susceptibility to
6LRP8TTBad[ClinVar] Myocardial infarction, susceptibility to, 1
6F5CCNeutral[PharmGKB] Thrombotic disease
6—CCBad[ClinVar] Obesity
6UCP2CTBad[ClinVar] BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 4
6PTGER2AGBad[ClinVar] Asthma, aspirin-induced, susceptibility to
6—AGBad[ClinVar] Obesity
6LGALS2AABad[ClinVar] Myocardial infarction, susceptibility to
6CD209AGBad[ClinVar] Mycobacterium tuberculosis, susceptibility to
6CDKAL1CGBad[ClinVar] Obesity
6HLA-CCTBad[ClinVar] HIV-1 VIREMIA, SUSCEPTIBILITY TO
5PADI2GTNeutral[ClinVar] Rheumatoid arthritis
5CACNA1CAANeutral[ClinVar] Post-traumatic stress disorder
5APCGTNeutral[ClinVar] Familial colorectal cancer
5TNFSF15CCNeutral[ClinVar] Leprosy, susceptibility to, 1
5IL1RL2CCNeutral[ClinVar] Ascending aortic dissection
5HSPA1ACGNeutral[ClinVar] Chronic obstructive pulmonary disease
5FSHBGTNeutral[ClinVar] Hypogonadotropic hypogonadism 24 without anosmia
5PCSK9CCNeutral[ClinVar] Familial hypercholesterolemia
5APCCTNeutral[ClinVar] Familial colorectal cancer
5APCAGNeutral[ClinVar] Familial colorectal cancer
5APCAGNeutral[ClinVar] Familial colorectal cancer
5SLC9A4AGNeutral[ClinVar] Ascending aortic dissection
5SMAD3CTNeutral[ClinVar] Lung cancer
5P2RY11GGNeutral[ClinVar] Cataplexy and narcolepsy
5APCATNeutral[ClinVar] Familial colorectal cancer
5PRICKLE1ACNeutral[ClinVar] ClinVar classifies this allele as unknown significance
5APCGTNeutral[ClinVar] Familial colorectal cancer
5IL1RL1AGNeutral[ClinVar] Ascending aortic dissection
5SLC24A4GTNeutral[ClinVar] SKIN/HAIR/EYE PIGMENTATION 6, BLOND/BROWN HAIR
5SLCO3A1CCNeutral[ClinVar] Vascular endothelial growth factor (VEGF) inhibitor response
5HERC2GGNeutral[ClinVar] SKIN/HAIR/EYE PIGMENTATION 1, BLUE/NONBLUE EYES
5HHIPAGNeutral[ClinVar] Chronic obstructive pulmonary disease, biomass related
5HHIPAGNeutral[ClinVar] Chronic obstructive pulmonary disease, biomass related
5FKBP5CCNeutral[ClinVar] Post-traumatic stress disorder
5DCTCCNeutral[ClinVar] Age related macular degeneration 7
5LNX1CTNeutral[ClinVar] Lip and oral cavity carcinoma
5SLC9A4TTNeutral[ClinVar] Ascending aortic dissection
5PPANTTNeutral[ClinVar] Cataplexy and narcolepsy
5TMEM132DCTNeutral[ClinVar] Vascular endothelial growth factor (VEGF) inhibitor response
5HERC2TTNeutral[ClinVar] SKIN/HAIR/EYE PIGMENTATION 1, BLUE/NONBLUE EYES
5RNF212AGNeutral[ClinVar] RECOMBINATION RATE QUANTITATIVE TRAIT LOCUS 1
5IL1BAGNeutral[ClinVar] Antisynthetase syndrome
5WWC1CTNeutral[ClinVar] Memory quantitative trait locus
5APCACNeutral[ClinVar] Familial colorectal cancer
5BMAL2CTNeutral[ClinVar] Pulmonary disease, chronic obstructive, susceptibility to
5IL6CGNeutral[ClinVar] Diabetes mellitus, type 1, susceptibility to
5EDNRAAGNeutral[ClinVar] Migraine, resistance to
5MCM6TTNeutral[ClinVar] LACTASE PERSISTENCE
5HHIPAGNeutral[ClinVar] Chronic obstructive pulmonary disease, biomass related
5CYP2C9GTNeutral[ClinVar] Pulmonary disease, chronic obstructive, susceptibility to
5MGST1AANeutral[ClinVar] Pulmonary disease, chronic obstructive, susceptibility to
5APCATNeutral[ClinVar] Familial colorectal cancer
5IL1RL1AANeutral[ClinVar] Ascending aortic dissection
5CYP2C8TTNeutral[ClinVar] Pulmonary disease, chronic obstructive, susceptibility to
5APCCTNeutral[ClinVar] Familial colorectal cancer
5APCGTNeutral[ClinVar] Familial colorectal cancer
5APCCGNeutral[ClinVar] Familial colorectal cancer
5PADI2CTNeutral[ClinVar] Rheumatoid arthritis
5AHSGAGNeutral[ClinVar] Nephrolithiasis, calcium oxalate
5CA9AGNeutral[ClinVar] Gastric cancer
5NOD2AGNeutral[ClinVar] Leprosy, susceptibility to, 1
5APCAGNeutral[ClinVar] Familial colorectal cancer
5RASGRP3GTNeutral[ClinVar] ClinVar classifies this allele as unknown significance
5PADI4CTNeutral[ClinVar] Rheumatoid arthritis
5IL18R1ACNeutral[ClinVar] Ascending aortic dissection
5APCAGNeutral[ClinVar] Familial colorectal cancer
5CDK6CTNeutral[ClinVar] Behcet disease
5P2RY11AANeutral[ClinVar] Cataplexy and narcolepsy
5BMP2AGNeutral[ClinVar] Lung cancer
5APCCTNeutral[ClinVar] Familial colorectal cancer
5APCAGNeutral[ClinVar] Familial colorectal cancer
5APCAGNeutral[ClinVar] Familial colorectal cancer
5APCCTNeutral[ClinVar] Familial colorectal cancer
5APCAGNeutral[ClinVar] Familial colorectal cancer
5MMP2CTNeutral[ClinVar] Lip and oral cavity carcinoma
5APCCTNeutral[ClinVar] Familial colorectal cancer
5APCCTNeutral[ClinVar] Familial colorectal cancer
5APCAGNeutral[ClinVar] Familial colorectal cancer
5APCAGNeutral[ClinVar] Familial colorectal cancer
5APCAANeutral[ClinVar] Familial colorectal cancer
5APCCCNeutral[ClinVar] Familial colorectal cancer
5SDC3CTNeutral[ClinVar] Obesity, association with
5APCAGNeutral[ClinVar] Familial colorectal cancer
5APCAGNeutral[ClinVar] Familial colorectal cancer
5APCGGNeutral[ClinVar] Familial colorectal cancer
5APCCGNeutral[ClinVar] Familial colorectal cancer
5APCCTNeutral[ClinVar] Familial colorectal cancer
5APCCTNeutral[ClinVar] Familial colorectal cancer
5APCCTNeutral[ClinVar] Familial colorectal cancer
5APCACNeutral[ClinVar] Familial colorectal cancer
5APCAGNeutral[ClinVar] Familial colorectal cancer
5APCACNeutral[ClinVar] Familial colorectal cancer
5APCAGNeutral[ClinVar] Familial colorectal cancer
5APCATNeutral[ClinVar] Familial colorectal cancer
5APCCTNeutral[ClinVar] Familial colorectal cancer
5HSPA1BCTNeutral[ClinVar] Chronic obstructive pulmonary disease
5APCGTNeutral[ClinVar] Familial colorectal cancer
5APCAGNeutral[ClinVar] Familial colorectal cancer
5APCAGNeutral[ClinVar] Familial colorectal cancer
5APCCGNeutral[ClinVar] Familial colorectal cancer
5APCCGNeutral[ClinVar] Familial colorectal cancer
5APCCGNeutral[ClinVar] Familial colorectal cancer
5AGERCTNeutral[ClinVar] COPD, severe early onset
5APCAGNeutral[ClinVar] Familial colorectal cancer
5APCAGNeutral[ClinVar] Familial colorectal cancer
5ABCC1AGNeutral[ClinVar] Familial cancer of breast
5APCGGNeutral[ClinVar] Familial colorectal cancer
5SCGB1A1AGNeutral[ClinVar] Chronic obstructive pulmonary disease
5OR2J3AGNeutral[ClinVar] C3HEX, ability to smell
5RNF212AGNeutral[ClinVar] RECOMBINATION RATE QUANTITATIVE TRAIT LOCUS 1
5TPCN2AANeutral[ClinVar] SKIN/HAIR/EYE PIGMENTATION, VARIATION IN, 10
5—AGNeutral[ClinVar] Familial colorectal cancer
5ABCC1AGNeutral[ClinVar] Familial cancer of breast
5APCGTNeutral[ClinVar] Familial colorectal cancer
5ARNT2CTNeutral[ClinVar] Pulmonary disease, chronic obstructive, susceptibility to
5APCAGNeutral[ClinVar] Familial colorectal cancer
5APCCTNeutral[ClinVar] Familial colorectal cancer
5APCCTNeutral[ClinVar] Familial colorectal cancer
5APCCTNeutral[ClinVar] Familial colorectal cancer
5RIPK2AGNeutral[ClinVar] Leprosy, susceptibility to, 1
5CXCL8ATNeutral[ClinVar] Cholangiocarcinoma
5APCCGNeutral[ClinVar] Familial colorectal cancer
5APCAGNeutral[ClinVar] Familial colorectal cancer
5APCAGNeutral[ClinVar] Familial colorectal cancer
5MGST3GTNeutral[ClinVar] Pulmonary disease, chronic obstructive, susceptibility to
5MGST1CCNeutral[ClinVar] Pulmonary disease, chronic obstructive, susceptibility to
5SLC6A2AANeutral[ClinVar] ClinVar classifies this allele as unknown significance
5RIPK2AGNeutral[ClinVar] Leprosy, susceptibility to, 1
5—ATNeutral[ClinVar] Familial colorectal cancer
5CDC20BAGNeutral[ClinVar] Gastric cancer
5—AGNeutral[ClinVar] Familial colorectal cancer
5TNFSF15TTNeutral[ClinVar] Leprosy, susceptibility to, 1
5APCCGNeutral[ClinVar] Familial colorectal cancer
5APCAGNeutral[ClinVar] Familial colorectal cancer
5APCGTNeutral[ClinVar] Familial colorectal cancer
5APCATNeutral[ClinVar] Familial colorectal cancer
5APCGTNeutral[ClinVar] Familial colorectal cancer
5APCAGNeutral[ClinVar] Familial colorectal cancer
5APCCGNeutral[ClinVar] Familial colorectal cancer
5APCAANeutral[ClinVar] Familial colorectal cancer
5APCATNeutral[ClinVar] Familial colorectal cancer
5FKBP5CTNeutral[ClinVar] Susceptibility to severe depressive disorder
5FKBP5GGNeutral[ClinVar] Susceptibility to severe depressive disorder
5CREB5GTNeutral[ClinVar] Vascular endothelial growth factor (VEGF) inhibitor response
5CCDC3CTNeutral[ClinVar] Lip and oral cavity carcinoma
5SLC9A4CTNeutral[ClinVar] Ascending aortic dissection
5FUT2AGNeutral[ClinVar] Familial Otitis Media
5BMAL2ACNeutral[ClinVar] Pulmonary disease, chronic obstructive, susceptibility to
5—AGNeutral[ClinVar] Familial colorectal cancer
5MCM6AANeutral[ClinVar] LACTASE PERSISTENCE
5IL1RL1CTNeutral[ClinVar] Ascending aortic dissection
5APCAGNeutral[ClinVar] Familial colorectal cancer
5APCCCNeutral[ClinVar] Familial colorectal cancer
5APCAGNeutral[ClinVar] Familial colorectal cancer
5APCAGNeutral[ClinVar] Familial colorectal cancer
5APCGTNeutral[ClinVar] Familial colorectal cancer
5APCCTNeutral[ClinVar] Familial colorectal cancer
5APCCGNeutral[ClinVar] Familial colorectal cancer
5APCCTNeutral[ClinVar] Familial colorectal cancer
5ZNF41CCNeutral[ClinVar] ClinVar classifies this allele as unknown significance
5FUT2AGNeutral[ClinVar] Familial Otitis Media
5HAO1CTNeutral[ClinVar] Nephrolithiasis, calcium oxalate
5APCGTNeutral[ClinVar] Familial colorectal cancer
5APCCTNeutral[ClinVar] Familial colorectal cancer
5SLC2A9TTNeutral[ClinVar] Uric acid concentration, serum, quantitative trait locus 2
5HSPA1BCTNeutral[ClinVar] Chronic obstructive pulmonary disease
5PINK1AGNeutral[ClinVar] Leprosy, susceptibility to, 1
5APCAGNeutral[ClinVar] Familial colorectal cancer
5APCAGNeutral[ClinVar] Familial colorectal cancer
5GPD1LAGNeutral[ClinVar] ClinVar classifies this allele as unknown significance
5FUT2CTNeutral[ClinVar] Familial Otitis Media
5APCAGNeutral[ClinVar] Familial colorectal cancer
5FKBP5CCNeutral[ClinVar] Susceptibility to severe depressive disorder
5SPNS2AGNeutral[ClinVar] Vascular endothelial growth factor (VEGF) inhibitor response
5FKBP5AGNeutral[ClinVar] Susceptibility to severe depressive disorder
5BGLAPAANeutral[ClinVar] Nephrolithiasis, calcium oxalate
5NOD2AGNeutral[ClinVar] Leprosy, susceptibility to, 1
5HERC2CCNeutral[ClinVar] SKIN/HAIR/EYE PIGMENTATION 1, BLUE/NONBLUE EYES
5MGST3AGNeutral[ClinVar] Pulmonary disease, chronic obstructive, susceptibility to